PTC Therapeutics, Inc. (PTCT)

SEC filing

PTC Therapeutics, Inc.

PTCT · CIK 1070081

4 · Feb 19, 2026 · Boulding Mark Elliott sold 5,894 shares at $69.33/share ($408.6K); exercised options for 2,813 shares

Boulding Mark Elliott sold 5,894 shares at $69.33/share ($408.6K); exercised options for 2,813 shares

xslF345X05/form4-02192026_050201.xml

xslF345X05/form4-02192026_050201.xmlSEC.gov

Graphics and non-inline formats (not embedded below).